Dmitry Oskin

Dr. Dmitry Oskin

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Stanislav KotlyarovStanislav Kotlyarov
Stanislav Kotlyarov
DODmitry Oskin
Dmitry Oskin
The comorbid course of chronic obstructive pulmonary disease (COPD) and pulmonary tuberculosis is an important medical and social problem. Both diseases, although having different etiologies, have many overlapping relationships that mutually influence their course and prognosis. The aim of the current review is to discuss the role of different immune mechanisms underlying inflammation in COPD and pulmonary tuberculosis. These mechanisms are known to involve both the innate and adaptive immune system, including various cellular and intercellular interactions. There is growing evidence that immune mechanisms involved in the pathogenesis of both COPD and tuberculosis may jointly contribute to the tuberculosis-associated obstructive pulmonary disease (TOPD) phenotype. Several studies have reported prior tuberculosis as a risk factor for COPD. Therefore, the study of the mechanisms that link COPD and tuberculosis is of considerable clinical interest.

18 January 2023 in Experimental and Clinical Gastroenterology
Verified
Journal Article
Open access
PDF file
DODmitry Oskin
Dmitry Oskin
EFE. V. Filippov
E. V. Filippov
Despite the study of the epidemiology of tuberculosis and its co-infection over the past decades, a number of questions remain, including those related to the impact of co-infection on survival depending on the chosen tuberculosis treatment regimen, the likelihood of adverse outcomes in the form of gastrointestinal bleeding and cirrhosis of the liver and their relationship with the therapy of the underlying disease. The purpose of the study: to evaluate the survival of patients with tuberculosis who have co-infection (viral hepatitis B and C) and receive multicomponent chemotherapy. Materials and Methods: The study included all patients who received treatment for active tuberculosis and had viral hepatitis B and/or C from 01/01/2004 to 12/31/2020. A total of 1687 patients were included. Twenty-two patients were lost to follow-up, and attempts to ascertain their clinical status were unsuccessful. Vital status was assessed in all patients. The mean duration of follow-up was 10.5±3.0 years. Median follow-up was 11.3 years (95% confidence interval (CI) 8.2-14.3). The average age of the cohort was 53.3±7.7 years. The study assessed survival and all-cause mortality annually. Results: The frequency of chronic hepatitis B in the group of patients with active tuberculosis was 3.8%, hepatitis C - 14.8%, hepatitis B and C - 0.5% of cases. Such an incidence of viral hepatitis is associated with a high frequency of illicit drug users (62.4%). It should be noted that the frequency of hepatitis treatment was low and amounted to 8.7%. When assessing the contribution of hepatitis B and C to the mortality of patients with active tuberculosis, it was found that hepatitis is not a predictor of death in patients. At the same time, patients who did not receive hepatitis therapy had a higher risk of death (unadjusted odds ratio (OR) - 1.28, 95% CI 1.04-1.65). The adjusted OR for hepatitis B was - 1.87 95% CI 0.67-1.52, C - 1.24 95% CI 0.90-2.18, B and C - 1.72 95% CI 0.99-2.02. Conclusion: The presence of chronic viral hepatitis B and/or C in patients with active tuberculosis did not affect mortality from all causes and regardless of the type of virus during a long period of observation. Patients who did not receive treatment for viral hepatitis and who had a history of tuberculosis had a higher risk of death from all causes (OR 1.28, 95% CI 1.04-1.65).

Verified
Journal Article
Open access
PDF file
DODmitry Oskin
Dmitry Oskin
Stanislav KotlyarovStanislav Kotlyarov
Stanislav Kotlyarov
Background/Objective: Chronic obstructive pulmonary disease (COPD) and tuberculosis (TB) are among the most prevalent respiratory disorders worldwide and frequently coexist in the same patient. However, the contribution of active TB and post-tuberculosis lung disease to COPD exacerbations and long-term prognosis remains incompletely defined. This paper aim to evaluate the prevalence, clinical correlates, and prognostic significance of tuberculosis and its sequelae in patients with COPD. Materials and methods: We conducted a population-based retrospective cohort study using de-identified data from the regional healthcare information system. The cohort included all adults aged 18 years or older with a recorded diagnosis of COPD (ICD-10 code J44). Tuberculosis was identified by codes A15–A19 and B90. The primary outcomes were COPD exacerbations and all-cause mortality. Group comparisons, cluster analysis, Kaplan–Meier survival analysis, Cox proportional hazards modeling, and multivariable logistic regression were performed. Results: Tuberculosis and/or its sequelae were identified in 267 of 16,714 patients (1.60%): post-TB sequelae (B90) in 197 (73.8%), active TB (A15–A19) in 22 (8.2%), and both in 48 (18.0%). Compared with patients without TB, those with COPD-TB were younger (63.5 ± 14.2 vs. 65.7 ± 14.7 years; p = 0.018), more often male (75.3% vs. 52.0%; p < 0.001), and had higher mortality (16.5% vs. 10.6%; p = 0.003). COPD-TB was associated with bronchiectasis (OR = 6.07; 95% CI, 3.03–12.16), pulmonary fibrosis (OR = 5.67; 95% CI, 3.40–9.45), and pneumonia (OR = 2.01; 95% CI, 1.50–2.71), but with lower prevalences of obesity, diabetes mellitus, and hypertension. Patients with TB experienced more COPD exacerbations, including recurrent exacerbations. In multivariable models, tuberculosis was associated with COPD exacerbations after adjustment for age and sex (adjusted OR = 1.43; 95% CI, 1.05–1.96); this association was attenuated and lost significance after further adjustment for post-tuberculosis structural lung disease, indicating that it is largely mediated by post-TB sequelae. Tuberculosis remained associated with mortality after adjustment for available covariates, both in logistic regression (adjusted OR = 1.61; 95% CI, 1.14–2.28) and in Cox analysis (hazard ratio = 1.37; 95% CI, 1.01–1.85). Conclusions: Tuberculosis and post-tuberculosis lung disease are clinically accessible risk markers associated with COPD exacerbations and mortality. These findings support recognizing patients with COPD and a history of TB as a high-risk subgroup requiring intensified follow-up, proactive exacerbation prevention, and prioritized vaccination counseling. In the context of personalized medicine, a documented history of tuberculosis and post-tuberculosis lung changes represents a clinically accessible marker that can be used to stratify individual risk and to tailor monitoring and prevention in patients with COPD.

Verified
Journal Article
Open access
PDF file
Stanislav KotlyarovStanislav Kotlyarov
Stanislav Kotlyarov
DODmitry Oskin
Dmitry Oskin
Chronic obstructive pulmonary disease (COPD) and pulmonary tuberculosis (TB) are major causes of morbidity and mortality worldwide. Epidemiologic studies indicate an increased risk of tuberculosis in patients with COPD; however, the shared molecular mechanisms underlying the pathogenesis of these two diseases remain insufficiently understood. Objective. Based on a comparative bioinformatics analysis of peripheral blood transcriptomic profiles in patients with COPD and pulmonary tuberculosis, to identify common systemic immune mechanisms associated with the pathogenesis of both diseases. Gene expression data from the NCBI GEO public database were analyzed. GSE34608 included blood samples from 8 patients with tuberculosis and 18 healthy controls. The GSE76705 dataset contained peripheral-blood samples from 364 former smokers (225 with COPD and 139 without). Functional enrichment (GO Biological Process and KEGG) was run in ShinyGO; protein–protein interaction networks were built in STRING, and the top-15 hub genes were ranked by the MCC algorithm in CytoHubba. In tuberculosis, 892 up-regulated and 1448 down-regulated genes were identified; in COPD, 520 up-regulated and 1329 down-regulated. Common upregulated DEGs are involved in toll-like receptor signaling pathways, NOD-like receptor signaling pathways, neutrophil extracellular trap (NET) formation, phagosomes, and tuberculosis. Downregulated genes in each of the diseases were associated with processes of transcriptional regulation and RNA metabolism, which may indicate common transcriptional abnormalities in COPD and tuberculosis. COPD and tuberculosis share common pathogenic mechanisms, including the activation of innate immune signaling pathways (TLR, NOD), neutrophilic inflammation, the formation of neutrophil extracellular traps (NETosis), and phagocyte dysfunction. The identified common genes and signaling pathways may serve as a basis for the development of biomarkers and therapeutic targets; however, they require further validation in independent cohorts.

27 December 2024 in I.P. Pavlov Russian Medical Biological Herald
Verified
Journal Article
Closed access
PDF file
VCVioletta Vyacheslavovna Chernaya
Violetta Vyacheslavovna Chernaya
EZElena E. Zhil’tSova
Elena E. Zhil’tSova
DODmitriy N. Os’kIn
Dmitriy N. Os’kIn
OBOl’gA V. Bakovetskaya
Ol’gA V. Bakovetskaya
TCTat’yAna M. Cherdantseva
Tat’yAna M. Cherdantseva
БВБаковецкая Ольга Викторовна
Баковецкая Ольга Викторовна
INTRODUCTION: There is an objective demand for models of sustainable recreational environmental management based on modern ecodiagnostics, landscape-environmental design and rehabilitation of the population. Achievements in molecular biology have expanded understanding of the role of environmental factors in pathophysiology of chronic dermatoses (CD). Of importance is analysis of the influence of environmentally friendly recreational urban landscapes on reducing the morbidity and increasing the inter-remission period in patients with chronic skin diseases. AIM: To develop a universal model of landscape-environmental planning of the sustainable nature management territories for environmental recreation and rehabilitation of patients with CD. MATERIALS AND METHODS: An analytical assessment of scientific opinions and methodological approaches to landscape-environmental planning is given. A system analysis of scientific publications, a comparative analysis of existing regulatory legal acts permitted to identify and evaluate problems of ecodiagnostics of recreational landscapes and rehabilitation of people with CD. A method of making a final environmental diagnosis of the territory was determined. A reconnaissance survey and route tours of the forest park of Ryazan were conducted, areas suitable for rehabilitation of urban residents including patients with CD, were identified. A survey was conducted among 112 patients with CD to elicit their perception of the rehabilitation urban landscape. RESULTS: A universal model for planning territories of sustainable nature management for environmental recreation and rehabilitation has been developed. To make a final ecological diagnosis of the territory, ‘Method for diagnosing the suitability of land plots and for toxic monitoring of territories for health resort recreation and medical and environmental recreation using human and animal cell cultures’ has been proposed. An algorithm for developing an individual program of environmental rehabilitation of persons suffering CD has been summarized. An analysis of the survey questionnaires showed that 101 people (90.2%) noted the beneficial effects of the surrounding nature, reduction of stress and improvement of skin condition; 68 (60.7%) respondents suggested making improvements to the surrounding urban environment. CONCLUSION: Well-equipped and comfortable green urban landscapes have a positive effect on the treatment and rehabilitation of patients with dermatological diseases. The use of a universal methodological model in planning urban recreational areas are relevant and timely. Actualization and modernization of landscape-environmental planning is an innovative task that offers an opportunity for multiplicative use of the developed model in public healthcare.

30 September 2024 in PERSONALITY IN A CHANGING WORLD: HEALTH, ADAPTATION, DEVELOPMENT
Verified
Journal Article
Closed access
RURyazan State Medical University
Ryazan State Medical University
DODmitry Oskin
Dmitry Oskin
MLM. O. Larina
M. O. Larina
NSN. V. Stroilova
N. V. Stroilova
AVA. N. Varnavsky
A. N. Varnavsky
NENational Research University Higher School of Economics
National Research University Higher School of Economics
This article proposes a framework for strengthening the use of online questionnaires in social work that measure subjective well-being and quality of life through the use of a Telegram bot, a mini-program within the Telegram messenger. An important aspect of using a Telegram bot is the ability to automate data collection, which significantly saves time for both participants and researchers. The bot can send reminders to complete the surveys at any time, which helps to increase involvement and provides professionals with timely information about subjective well-being and quality of life. This is especially important in the context of long-term care, where well-established feedback can help identify problems at an early stage and adjust the approach to individual care. The purpose of the study is to assess the level of satisfaction with the Telegram bot @SocialNursingBot by citizens included in the long-term care system. To assess satisfaction, the System Usability Scale analysis method was used a standard tool widely used in user experience research. The study is based on the need to improve the accessibility and convenience of conducting surveys. Using a Telegram bot significantly simplifies this process, permitting to receive feedback in real time. The bot's interface is intuitive, which promotes active user participation and reduces the barrier to obtaining information.